CFDA Released 9 Technical Review Guidelines
On September 28th, CMDE issued 4 medical device technical review guidelines for comments 1. Drug Eluting Coronary Stent System Preclinical Study Technical Review Guideline. 2.
Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
On September 28th, CMDE issued 4 medical device technical review guidelines for comments 1. Drug Eluting Coronary Stent System Preclinical Study Technical Review Guideline. 2.

On October 8, in a government news conference in Beijing, the State Council issued the “Opinion on Encouraging the Innovation of Drugs and Medical Devices

Current Regulatory Process and Reform Companies interested in entering the Chinese market for innovative medical devices and treatments must first overcome existing barriers to market

China Biologic Products Holdings, Inc. (CBPO), a public company traded on the NASDAQ, today announced that it acquired 80% equity interest in Tianxinfu Medical Appliance

NORTH ANDOVER, Mass. – October 1, 2017 – China Med Device, LLC (CMD), a leader in helping medical technology companies enter the Chinese marketplace, congratulates

China and U.S. Agencies Met to Further Their Drug Medical Device Regulatory Cooperation Recently, CFDA’s International Cooperation Bureau in conjunction with the Center for Drug

WuXi AppTec’s Laboratory Testing Division (LTD) has launched preclinical medical device testing services in China. These services are being offered for Chinese and international clients

So what is the hottest and promising medical device in China? They are neither medical image devices, orthopedic implants, stents and other high-value supplies, nor

Here is the latest CFDA publication about Medical Device Classification Workflow For Overseas Companies: A. The application method Applicants can apply by visiting http://www.nifdc.org.cn/qxbgzx/CL0482/, clicking

For a long time, overseas drug and medical device companies have issues over China’s slow registration and approval process. This could result in delaying market

China is looking to speed up approvals for new drugs and devices and plans to accept data from clinical trials carried out overseas, a potential

China Brain Project to Focus on Brain Science and Research as Part of 13th Five-Year Plan Brain science has become a hot topic in global